Notification of Denominator Information – MDxHealth SA
8/3/2012 10:37:06 AM
IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, previously announced on June 29 the successful capital increase of €10 million through a private placement. As a result of this capital increase, the denominator or issued shares with voting rights changed from 18,622,327 to 25,513,440. Each shareholder of the Company is entitled to one vote per share.
comments powered by